The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...

Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...

If you’ve been diagnosed with major depressive disorder or a form of anxiety, your mental health provider may prescribe the ...

A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.

CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

One-third of folks with major depressive disorder experience treatment-resistant depression (TRD), a condition that makes it ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...

Biochemical analyses provide an answer to the question of how the gut bacterium Morganella morganii might contribute to some ...

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...